BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37159953)

  • 21. Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea.
    Mason M; Cates CJ; Smith I
    Cochrane Database Syst Rev; 2015 Jul; (7):CD011090. PubMed ID: 26171909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel nasal expiratory positive airway pressure (EPAP) device for the treatment of obstructive sleep apnea: a randomized controlled trial.
    Berry RB; Kryger MH; Massie CA
    Sleep; 2011 Apr; 34(4):479-85. PubMed ID: 21461326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acetazolamide Reduces Blood Pressure and Sleep-Disordered Breathing in Patients With Hypertension and Obstructive Sleep Apnea: A Randomized Controlled Trial.
    Eskandari D; Zou D; Grote L; Hoff E; Hedner J
    J Clin Sleep Med; 2018 Mar; 14(3):309-317. PubMed ID: 29510792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of a novel oral appliance and the role of posture on nasal resistance in obstructive sleep apnea.
    Tong BK; Tran C; Ricciardiello A; Chiang A; Donegan M; Murray N; Szollosi I; Amatoury J; Carberry JC; Eckert DJ
    J Clin Sleep Med; 2020 Apr; 16(4):483-492. PubMed ID: 32003735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug therapy for obstructive sleep apnoea in adults.
    Smith I; Lasserson TJ; Wright J
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003002. PubMed ID: 16625567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-Induced Sedation Endoscopy in the Evaluation of OSA Patients with Incomplete Oral Appliance Therapy Response.
    Kent DT; Rogers R; Soose RJ
    Otolaryngol Head Neck Surg; 2015 Aug; 153(2):302-7. PubMed ID: 26044788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Novel Model to Estimate Key Obstructive Sleep Apnea Endotypes from Standard Polysomnography and Clinical Data and Their Contribution to Obstructive Sleep Apnea Severity.
    Dutta R; Delaney G; Toson B; Jordan AS; White DP; Wellman A; Eckert DJ
    Ann Am Thorac Soc; 2021 Apr; 18(4):656-667. PubMed ID: 33064953
    [No Abstract]   [Full Text] [Related]  

  • 28. The presence of insomnia and depression contributes to the acceptance of an initial treatment trial of continuous positive airway pressure therapy in patients with obstructive sleep apnea.
    Drakou T; Steiropoulos P; Saroglou M; Georgopoulou A; Kazis D; Papagiannopoulos S; Porpodis K; Tryfon S
    Sleep Breath; 2021 Dec; 25(4):1803-1812. PubMed ID: 33411189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the combination of atomoxetine and oxybutynin in Japanese patients with obstructive sleep apnoea: A randomized controlled crossover trial.
    Kinouchi T; Terada J; Sakao S; Koshikawa K; Sasaki T; Sugiyama A; Sato S; Sakuma N; Abe M; Shikano K; Hayama N; Shiko Y; Ozawa Y; Ikeda S; Suzuki T; Tatsumi K
    Respirology; 2023 Mar; 28(3):273-280. PubMed ID: 36184258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous positive airway pressure device-based automated detection of obstructive sleep apnea compared to standard laboratory polysomnography.
    Prasad B; Carley DW; Herdegen JJ
    Sleep Breath; 2010 Jun; 14(2):101-7. PubMed ID: 19826848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a physiological-based model that uses standard polysomnography and clinical data to predict oral appliance treatment outcomes in obstructive sleep apnea.
    Dutta R; Tong BK; Eckert DJ
    J Clin Sleep Med; 2022 Mar; 18(3):861-870. PubMed ID: 34710038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): A Randomized Controlled Trial.
    Schweitzer PK; Taranto-Montemurro L; Ojile JM; Thein SG; Drake CL; Rosenberg R; Corser B; Abaluck B; Sangal RB; Maynard J
    Am J Respir Crit Care Med; 2023 Dec; 208(12):1316-1327. PubMed ID: 37812772
    [No Abstract]   [Full Text] [Related]  

  • 33. Nocturnal blood pressure and nocturnal blood pressure fluctuations: the effect of short-term CPAP therapy and their association with the severity of obstructive sleep apnea.
    Picard F; Panagiotidou P; Tammen AB; Wolf-Pütz A; Steffen M; Gerhardy HJ; Waßenberg S; Klein RM
    J Clin Sleep Med; 2022 Feb; 18(2):361-371. PubMed ID: 34314347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous positive airway pressure and adverse cardiovascular events in obstructive sleep apnea: are participants of randomized trials representative of sleep clinic patients?
    Reynor A; McArdle N; Shenoy B; Dhaliwal SS; Rea SC; Walsh J; Eastwood PR; Maddison K; Hillman DR; Ling I; Keenan BT; Maislin G; Magalang U; Pack AI; Mazzotti DR; Lee CH; Singh B
    Sleep; 2022 Apr; 45(4):. PubMed ID: 34739082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating the Clinical Performance of a Novel, Precision Oral Appliance Therapy Medical Device Made Wholly From a Medical Grade Class VI Material for the Treatment of Obstructive Sleep Apnea.
    Sall E; Smith K; Desai A; Carollo JA; Murphy MT; Kim S; Liptak LA
    Cureus; 2023 Dec; 15(12):e50107. PubMed ID: 38077673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive and behavioral therapy for insomnia increases the use of continuous positive airway pressure therapy in obstructive sleep apnea participants with comorbid insomnia: a randomized clinical trial.
    Sweetman A; Lack L; Catcheside PG; Antic NA; Smith S; Chai-Coetzer CL; Douglas J; O'grady A; Dunn N; Robinson J; Paul D; Williamson P; McEvoy RD
    Sleep; 2019 Dec; 42(12):. PubMed ID: 31403168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug therapy for obstructive sleep apnoea in adults.
    Mason M; Welsh EJ; Smith I
    Cochrane Database Syst Rev; 2013 May; (5):CD003002. PubMed ID: 23728641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects on obstructive sleep apnea severity following a tailored behavioral sleep medicine intervention aimed at increased physical activity and sound eating: an 18-month follow-up of a randomized controlled trial.
    Spörndly-Nees S; Åsenlöf P; Lindberg E; Emtner M; Igelström H
    J Clin Sleep Med; 2020 May; 16(5):705-713. PubMed ID: 32024584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of hypnotics on obstructive sleep apnea endotypes and severity: Novel insights into pathophysiology and treatment.
    Carter SG; Eckert DJ
    Sleep Med Rev; 2021 Aug; 58():101492. PubMed ID: 33965721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of an Interdisciplinary Weight Loss and Lifestyle Intervention on Obstructive Sleep Apnea Severity: The INTERAPNEA Randomized Clinical Trial.
    Carneiro-Barrera A; Amaro-Gahete FJ; Guillén-Riquelme A; Jurado-Fasoli L; Sáez-Roca G; Martín-Carrasco C; Buela-Casal G; Ruiz JR
    JAMA Netw Open; 2022 Apr; 5(4):e228212. PubMed ID: 35452108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.